EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents

Marta Chuncia-Ileczko, Witold Czyż, Julia Kacperczyk, Filip Arczewski, Karol Dziedzic, Julia Kulbacka, Maciej Wojszczyk, Damian Zys, Piotr Pasek, Julia Ryniecka

Quality in Sport · 06.01.2025 · 37 · 57200

DOI: 10.12775/qs.2025.37.57200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 06.01.2025. Verfasst von Marta Chuncia-Ileczko und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sex hormones have a key impact on the development of the human body during puberty, including a significant influence on bone development - their shape, structure, length, and mineral density. Due to the growing number of transgender and gender diverse (TGD) adolescents and the increasing demand for gender-affirming hormone therapy (GAHT), there is rising curiosity about the impact of this therapy on the developing body of a young person.

Purpose

This review aims to summarize the latest scientific reports on the impact of gonadotropin-releasing hormone analogues (GnRHas) and GAHT on the bone mineral density (BMD) of transgender adolescents undergoing gender-changing therapies.

Findings

Low pretreatment BMD is more common among TGD adolescents than in the general population, and this is more prevalent in transgirls than in transboys. BMD Z-scores decline during treatment with GnRHas and respond differentially to GAHT. Regular follow-up and health advice are essential. Further long-term studies of the effects of these therapies on peak bone mass and future fracture risk are needed.

Zitieren

APA

Chuncia-Ileczko, M., Czyż, W., Kacperczyk, J., Arczewski, F., Dziedzic, K., Kulbacka, J., Wojszczyk, M., Zys, D., Pasek, P., & Ryniecka, J. (2025). Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents. Quality in Sport, 37, 57200. https://doi.org/10.12775/qs.2025.37.57200

Vancouver

Chuncia-Ileczko M, Czyż W, Kacperczyk J, Arczewski F, Dziedzic K, Kulbacka J, et al. Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents. Quality in Sport. 2025;37:57200. doi:10.12775/qs.2025.37.57200

BibTeX
@article{ChunciaIleczko2025,
  author = {Chuncia-Ileczko, Marta and Czyż, Witold and Kacperczyk, Julia and Arczewski, Filip and Dziedzic, Karol and Kulbacka, Julia and Wojszczyk, Maciej and Zys, Damian and Pasek, Piotr and Ryniecka, Julia},
  title = {Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents},
  journal = {Quality in Sport},
  year = {2025},
  volume = {37},
  pages = {57200},
  doi = {10.12775/qs.2025.37.57200}
}
Kostenlos starten →